Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Solid Tumors × Ipilimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 203 Carcinoma, Non-Small-Cell Lung 61 Carcinoma, Renal Cell 53 Neoplasm Metastasis 44 Neoplasms 34 Prostatic Neoplasms 30 Uveal Melanoma 25 Carcinoma, Hepatocellular 23 Lung Neoplasms 22 Pancreatic Neoplasms 21 Breast Neoplasms 20 Brain Neoplasms 20 Sarcoma 19 Colorectal Neoplasms 19 Squamous Cell Carcinoma of Head and Neck 16 Small Cell Lung Carcinoma 16 Skin Neoplasms 16 Kidney Neoplasms 15 Carcinoma, Transitional Cell 14 Ovarian Neoplasms 13 Urinary Bladder Neoplasms 12 Diabetes Mellitus, Insulin-Dependent, 12 12 Uterine Cervical Neoplasms 11 Triple Negative Breast Neoplasms 11 Mesothelioma 11 Stomach Neoplasms 10 Recurrence 10 Head and Neck Neoplasms 10 Multiple Myeloma 9 Glioblastoma 9

Interventions

Injections 20 Carboplatin 16 Docetaxel 13 Paclitaxel 10 Bevacizumab 10 pembrolizumab 9 Cisplatin 7 durvalumab 6 Fluorouracil 6 tislelizumab 5 linifanib 5 Pemetrexed 5 Nivolumab 5 Leucovorin 5 trifluridine tipiracil drug combination 4 talazoparib 4 olaparib 4 Oxaliplatin 4 Irinotecan 4 Capecitabine 4 zimberelimab 3 toripalimab 3 sintilimab 3 fludarabine 3 depatuxizumab 3 atezolizumab 3 S 1 (combination) 3 Panobinostat 3 Itraconazole 3 Gemcitabine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03461952 2024-02-22

NIMBLe

Canadian Cancer Trials Group

Phase 2 Terminated

4 enrolled 4 charts

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡